ArticleAdvances in therapy2022

The Hospitalization-Related Costs of Adverse Events for Novel Androgen Receptor Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: An Indirect Comparison.

Neal Shore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.